Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21967102 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR1CNR2LPAR3LPAR2 | |
| SCHEMBL21967101 | 0.88 | LPAR2 (0.31) | LPAR3LPAR2LPAR1 | |
| SCHEMBL21967108 | 0.88 | LPAR2 (0.31) | LPAR3LPAR2LPAR1 | |
| SCHEMBL21670643 | 0.79 | THRB (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL21967082 | 0.79 | THRB (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL21670606 | 0.79 | THRB (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL3504051 | 0.79 | THRB (0.32) | ALDH1A1CYP3A4 | |
| SCHEMBL21967115 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL21967107 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CNR1CNR2MEN1CYP3A4 | |
| SCHEMBL21967083 | 0.79 | ALDH1A1 (0.37) | ALDH1A1CNR1CNR2MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110551009-B | Process for the preparation of (2E, 6Z) -2, 6-nonenal and (2E) -cis-6, 7-epoxy-2-nonenal | 信越化学工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-26 | — | — | US | disclosed |
| CN-110551009-A | Process for the preparation of (2E,6Z) -2, 6-nonadienal and (2E) -cis-6, 7-epoxy-2-nonenal | SHINETSU CHEMICAL CO | 2019-12-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662166-B2 | Process for preparing (2E,6Z)-2,6-nonadienal and a process for preparing (2E)-cis 6,7-epoxy-2-nonenal | CYP2E1, CYP2A6, CYP2J2 | ALDH1A1 46/4885CNR1 1693/4885CNR2 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.